A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days

Clinical trial NCT02140320 · COMPLETED

Trial details

NCT number: NCT02140320
Sponsor: Respivert Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Asthma Healthy Volunteers

Start date: 2014-07-01
Primary completion: 2015-03-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.